Literature DB >> 25606094

Depression in primary care part 2: management.

Xv Pereira1, Am Zainab2.   

Abstract

The management of depression in the primary care setting should ideally take a biological, psychological, and sociological approach. Antidepressants are the most commonly used biological agents in the treatment of depression. Psychological therapies and psychosocial interventions improve the outcome of treatment when combined with pharmacotherapy. Clinical depression is treatable and thus efforts should be made to alleviate the suffering of patients with depression.

Entities:  

Keywords:  Depression; antidepressants; psychotherapy

Year:  2007        PMID: 25606094      PMCID: PMC4170348     

Source DB:  PubMed          Journal:  Malays Fam Physician        ISSN: 1985-2274


  6 in total

Review 1.  Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association.

Authors: 
Journal:  Am J Psychiatry       Date:  2000-04       Impact factor: 18.112

2.  Use of antidepressant medications in the general practice setting. A critical review.

Authors:  Kelsey Hegarty; David Ames; Jeremy Anderson; Caroline Johnson; Roslyn McKinnon; Rob Moulds
Journal:  Aust Fam Physician       Date:  2003-04

Review 3.  St. John's wort for depression.

Authors:  Wail Malaty
Journal:  Am Fam Physician       Date:  2005-04-01       Impact factor: 3.292

Review 4.  FPIN's clinical inquiries. Psychosocial interventions delivered by primary care physicians to patients with depression.

Authors:  Molly S Clark; Patrick O Smith; Thomas J Payne; Vincent Lo
Journal:  Am Fam Physician       Date:  2006-11-01       Impact factor: 3.292

5.  Depressive illness--the need for a paradigm shift in its understanding and management.

Authors:  M Parameshvara Deva
Journal:  Med J Malaysia       Date:  2006-03

Review 6.  Diagnosis and management of depression in primary care: a clinical update and review.

Authors:  Ronald A Remick
Journal:  CMAJ       Date:  2002-11-26       Impact factor: 8.262

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.